Stanford University medical scientists have developed a novel imaging agent that could be used to identify most bacterial infections. The study is the featured basic science article in The Journal of Nuclear Medicine’s October issue. {read more here}

The results show that 6″-18F-fluoromaltotriose was taken up in both gram-positive and gram-negative bacterial strains, and it was able to detect Pseudomonas aeruginosa in a clinically relevant mouse model of wound infection.  {read more here}

The researchers used several increasingly complex models to determine the influence of tau and Aβ on SCD after accounting for covariates that included age, educational attainment, sex, depressive symptoms, and delay from neuropsychological testing to FTP-PET scanning. {read more here}

Thus, molecular imaging by means of PSMA-PET/CT also has an important role as a stratification criterion, and the ‘theranostic’ concept [combining diagnostic imaging of a biomarker with precise therapy] may be an additional motivation to establish PSMA-PET/CT as a routinely available imaging modality.” {read more here}